SG11201506679QA - Pharmaceutical composition comprising albumin-binding arginine deiminase for cancer targeting treatment - Google Patents
Pharmaceutical composition comprising albumin-binding arginine deiminase for cancer targeting treatmentInfo
- Publication number
- SG11201506679QA SG11201506679QA SG11201506679QA SG11201506679QA SG11201506679QA SG 11201506679Q A SG11201506679Q A SG 11201506679QA SG 11201506679Q A SG11201506679Q A SG 11201506679QA SG 11201506679Q A SG11201506679Q A SG 11201506679QA SG 11201506679Q A SG11201506679Q A SG 11201506679QA
- Authority
- SG
- Singapore
- Prior art keywords
- albumin
- pharmaceutical composition
- arginine deiminase
- cancer targeting
- targeting treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/03—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amidines (3.5.3)
- C12Y305/03006—Arginine deiminase (3.5.3.6)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361773214P | 2013-03-06 | 2013-03-06 | |
| US14/197,236 US9255262B2 (en) | 2013-03-06 | 2014-03-05 | Albumin-binding arginine deminase and the use thereof |
| PCT/US2014/020943 WO2014138319A2 (en) | 2013-03-06 | 2014-03-06 | Pharmaceutical composition comprising albumin-binding arginine deiminase for cancer targeting treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201506679QA true SG11201506679QA (en) | 2015-09-29 |
Family
ID=51488086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201506679QA SG11201506679QA (en) | 2013-03-06 | 2014-03-06 | Pharmaceutical composition comprising albumin-binding arginine deiminase for cancer targeting treatment |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US9255262B2 (ko) |
| EP (1) | EP2964761B1 (ko) |
| JP (1) | JP6243452B2 (ko) |
| KR (1) | KR102139844B1 (ko) |
| CN (1) | CN105142663B (ko) |
| AP (1) | AP2015008714A0 (ko) |
| AU (1) | AU2014225712C1 (ko) |
| BR (1) | BR112015021182A2 (ko) |
| CA (1) | CA2903152C (ko) |
| CL (1) | CL2015002479A1 (ko) |
| EA (1) | EA036064B1 (ko) |
| ES (1) | ES2909664T3 (ko) |
| HK (1) | HK1211979A1 (ko) |
| IL (1) | IL240976A (ko) |
| MA (1) | MA38376B1 (ko) |
| MX (1) | MX2015011578A (ko) |
| MY (1) | MY175144A (ko) |
| PH (1) | PH12015501995A1 (ko) |
| SA (1) | SA515360970B1 (ko) |
| SG (1) | SG11201506679QA (ko) |
| TW (1) | TWI634212B (ko) |
| WO (1) | WO2014138319A2 (ko) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9255262B2 (en) * | 2013-03-06 | 2016-02-09 | Vision Global Holdings Ltd. | Albumin-binding arginine deminase and the use thereof |
| MX2016005013A (es) | 2013-10-18 | 2017-02-28 | Deutsches Krebsforsch | Inhibidores marcados de antigeno prostatico especifico de membrana (psma), su uso como agentes formadores de imagenes y agentes farmaceuticos para el tratamiento de cancer de prostata. |
| CN105985447B (zh) * | 2015-03-02 | 2019-10-22 | 四川大学华西医院 | 一种白蛋白结合型肿瘤坏死因子相关凋亡诱导配体变异体及其制备方法和用途 |
| CN104789489B (zh) * | 2015-03-09 | 2018-01-23 | 武汉远大弘元股份有限公司 | 一株高产精氨酸脱亚胺酶的蜡样芽孢杆菌及其应用 |
| US20190352365A1 (en) * | 2017-01-18 | 2019-11-21 | Savior Lifetec Corporation | Expression construct and method for producing proteins of interest |
| EP3449935A1 (en) * | 2017-08-31 | 2019-03-06 | Erytech Pharma | Arginine deiminase encapsulated inside erythrocytes and their use in treating cancer and arginase-1 deficiency |
| JP2021525749A (ja) * | 2018-05-31 | 2021-09-27 | ザ ホンコン ポリテクニック ユニバーシティ | 癌、肥満、代謝障害及び関連する合併症と併存症のためのアルギニン枯渇剤の組成と応用 |
| WO2021041954A2 (en) * | 2019-08-28 | 2021-03-04 | The Research Foundation For The State University Of New York | Targeted delivery of tumor matrix modifying enzymes |
| CN111394295B (zh) * | 2019-11-06 | 2023-03-10 | 上海健康医学院 | 一种制备固定化精氨酸脱亚胺酶及生产[14/15n]-l-瓜氨酸的方法 |
| CN111518851B (zh) * | 2019-11-06 | 2023-05-23 | 上海健康医学院 | 一种固定化酶连续制备[14/15n]-l-瓜氨酸的方法 |
| EP4069280A4 (en) * | 2019-12-02 | 2024-01-03 | The Hong Kong Polytechnic University | METHODS FOR INDUCING INTERMITTENT FASTING AND MODULATING AUTOPHAGY |
| US20230372503A1 (en) * | 2020-09-25 | 2023-11-23 | Proabtech Inc. | Conjugate of functional polypeptide variant, and use thereof |
| CN113584054B (zh) * | 2021-06-28 | 2023-04-18 | 河北远大九孚生物科技有限公司 | 编码精氨酸脱亚胺酶的dna分子及其用途 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2900279B2 (ja) * | 1989-08-02 | 1999-06-02 | 株式会社ジャパンエナジー | 新規なアルギニンデイミナーゼ、その製造法及び該酵素を有効成分とする制癌剤 |
| US5196195A (en) * | 1990-03-27 | 1993-03-23 | Cornell Research Foundation, Inc. | Use of arginase to control nitric oxide formation |
| FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| US5804183A (en) * | 1997-01-31 | 1998-09-08 | Enzon, Inc. | Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same |
| US6183738B1 (en) | 1997-05-12 | 2001-02-06 | Phoenix Pharamacologics, Inc. | Modified arginine deiminase |
| US6180387B1 (en) * | 1997-08-11 | 2001-01-30 | Smithkline Beecham Corporation | Arginine deiminase |
| GB9823071D0 (en) * | 1998-10-21 | 1998-12-16 | Affibody Technology Ab | A method |
| US20040001827A1 (en) | 2002-06-28 | 2004-01-01 | Dennis Mark S. | Serum albumin binding peptides for tumor targeting |
| US6926898B2 (en) * | 2000-04-12 | 2005-08-09 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US20030157091A1 (en) | 2002-02-14 | 2003-08-21 | Dyax Corporation | Multi-functional proteins |
| EP1551762B1 (en) | 2002-05-20 | 2010-10-27 | Danisco US Inc. | Peptide derivatives, and their use for the synthesis of silicon-based composite materials |
| SI1729795T1 (sl) * | 2004-02-09 | 2016-04-29 | Human Genome Sciences, Inc. | Albuminski fuzijski proteini |
| CN1292002C (zh) * | 2004-10-21 | 2006-12-27 | 北京双鹭药业股份有限公司 | 一种精氨酸脱酰酶融合蛋白、其制造方法及应用 |
| MX342271B (es) | 2005-05-18 | 2016-09-21 | Ablynx Nv | Nanobodiestm (nanocuerpos) mejorados contra el factor alfa de necrosis del tumor. |
| CN101002945B (zh) * | 2006-01-20 | 2012-09-05 | 清华大学 | 一种用于肿瘤治疗的新型复合物 |
| KR100934656B1 (ko) | 2006-02-06 | 2009-12-31 | 엘지전자 주식회사 | 다중 반송파 시스템에서의 무선 자원 할당 방법 |
| EP2474318A1 (en) * | 2006-06-07 | 2012-07-11 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US8313924B2 (en) | 2006-08-01 | 2012-11-20 | Pieris Ag | Muteins of tear lipocalin and methods for obtaining the same |
| EP2190863B1 (en) * | 2007-07-31 | 2015-09-02 | Affibody AB | New albumin binding compositions, methods and uses |
| EP2295560A1 (en) | 2009-09-14 | 2011-03-16 | RWTH Aachen University | Directed evolution of arginine deiminase for increased activity at physiological pH |
| US9255262B2 (en) * | 2013-03-06 | 2016-02-09 | Vision Global Holdings Ltd. | Albumin-binding arginine deminase and the use thereof |
-
2014
- 2014-03-05 US US14/197,236 patent/US9255262B2/en not_active Ceased
- 2014-03-06 MA MA38376A patent/MA38376B1/fr unknown
- 2014-03-06 BR BR112015021182A patent/BR112015021182A2/pt not_active Application Discontinuation
- 2014-03-06 TW TW103107618A patent/TWI634212B/zh active
- 2014-03-06 KR KR1020157027321A patent/KR102139844B1/ko active IP Right Grant
- 2014-03-06 WO PCT/US2014/020943 patent/WO2014138319A2/en active Application Filing
- 2014-03-06 AU AU2014225712A patent/AU2014225712C1/en active Active
- 2014-03-06 EP EP14760354.2A patent/EP2964761B1/en active Active
- 2014-03-06 ES ES14760354T patent/ES2909664T3/es active Active
- 2014-03-06 JP JP2015561630A patent/JP6243452B2/ja active Active
- 2014-03-06 MX MX2015011578A patent/MX2015011578A/es unknown
- 2014-03-06 SG SG11201506679QA patent/SG11201506679QA/en unknown
- 2014-03-06 CA CA2903152A patent/CA2903152C/en active Active
- 2014-03-06 AP AP2015008714A patent/AP2015008714A0/xx unknown
- 2014-03-06 CN CN201480012426.7A patent/CN105142663B/zh active Active
- 2014-03-06 MY MYPI2015702796A patent/MY175144A/en unknown
- 2014-03-06 EA EA201500826A patent/EA036064B1/ru not_active IP Right Cessation
-
2015
- 2015-09-01 SA SA515360970A patent/SA515360970B1/ar unknown
- 2015-09-01 IL IL240976A patent/IL240976A/en active IP Right Grant
- 2015-09-04 CL CL2015002479A patent/CL2015002479A1/es unknown
- 2015-09-08 PH PH12015501995A patent/PH12015501995A1/en unknown
- 2015-12-23 HK HK15112653.6A patent/HK1211979A1/xx unknown
- 2015-12-28 US US14/981,855 patent/US9803185B2/en not_active Ceased
-
2017
- 2017-07-25 US US15/658,685 patent/USRE47233E1/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1211979A1 (en) | Pharmaceutical composition comprising albumin-binding arginine deiminase for cancer targeting treatment | |
| HK1209021A1 (en) | Nanotherapeutics for drug targeting | |
| HUE044611T2 (hu) | Gyógyászati készítmény rák kezelésére | |
| HK1206297A1 (en) | Pharmaceutical compositions for combination therapy | |
| HUE045461T2 (hu) | Gyógyászati készítmény rák kezelésére | |
| HK1207861A1 (en) | Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer bub1 | |
| HK1221424A1 (zh) | 治療癌症的藥物組合 | |
| HK1215191A1 (zh) | 低劑量醫藥組合物 | |
| HRP20190050T1 (hr) | Farmaceutski pripravci za kombinacijsku terapiju | |
| HK1222548A1 (zh) | 治療惡性腫瘤的藥物組合 | |
| GB201322626D0 (en) | Combined preparations for the treatment of cancer | |
| HK1210710A1 (en) | Pharmaceutical composition comprising rebamipide | |
| EP3088001A4 (en) | Therapeutic drug for malignant tumors | |
| EP2823825A4 (en) | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER | |
| EP3020399A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER | |
| EP2934500A4 (en) | COMBINATION THERAPY AGAINST CANCER | |
| PL2855475T3 (pl) | Alfa-karboliny do leczenia nowotworu | |
| ZA201502571B (en) | Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines | |
| IL238267B (en) | Anthracycline derivatives for the treatment of tumor diseases | |
| IL239231A0 (en) | Combined cancer treatment | |
| AU2013904239A0 (en) | Pharmaceutical combinations for the treatment of cancer | |
| HUE043019T2 (hu) | Gyógyszerészeti készítmények kombinációs terápia céljára |